Caliway Biopharmaceuticals

TPE-6919
Taiwan Stock Exchange
Healthcare Biotechnology
Global Rank
#2338
Country Rank
#46
Market Cap
8.22 B
Price
5.81
Change (%)
9.72%
Volume
34.54 M

Caliway Biopharmaceuticals's latest marketcap:

8.22 B

As of 08/19/2025, Caliway Biopharmaceuticals's market capitalization has reached $8.22 B. According to our data, Caliway Biopharmaceuticals is the 2338th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.22 B
Revenue (ttm) 1.49 M
Net Income (ttm) -20,536,465.42
Shares Out 1.55 B
EPS (ttm) -0.01
Forward PE 62.45
Ex-Dividend Date n/a
Earnings Date 08/11/2025
Market Cap Chart
Data Updated: 08/19/2025

Caliway Biopharmaceuticals's yearly market capitalization.

Caliway Biopharmaceuticals has seen its market value grow from NT$7.53 B to NT$247.39 B since 2022, representing a total increase of 3,186.13% and an annual compound growth rate (CAGR) of 275.86%.
Date Market Cap(NT$) Market Cap(USD) Change (%) Global Rank
08/19/2025 NT$247.39 B $8.22 B 138.33% 2338
12/31/2024 NT$94.36 B $2.87 B 300.87% 4489
12/29/2023 NT$23.54 B $765.75 M 212.69% 10223
12/30/2022 NT$7.53 B $245.8 M 16807

Company Profile

Caliway Biopharmaceuticals Co. Ltd

Industry: Biotechnology & Pharmaceuticals

Specialization: Small molecule drug development for medical aesthetics and inflammatory diseases.

Founded: 2012

Headquarters: New Taipei City, Taiwan

Caliway Biopharmaceuticals focuses on innovative therapeutic solutions, leveraging its expertise in small molecule drugs to address unmet medical needs in aesthetics and inflammation.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.